Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

86 filings reported holding BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share as of Q2 2021.
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26,920,427 shares .
Largest 10 shareholders include BAILLIE GIFFORD & CO (8,462,422 shares), MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC (1,990,408 shares), ORBIMED ADVISORS LLC (1,856,201 shares), BlackRock Inc. (1,735,307 shares), JENNISON ASSOCIATES LLC (1,699,809 shares), CANADA PENSION PLAN INVESTMENT BOARD (1,238,000 shares), Sumitomo Mitsui Trust Holdings, Inc. (866,572 shares), AMERIPRISE FINANCIAL INC (857,263 shares), Nikko Asset Management Americas, Inc. (761,503 shares), and GILDER GAGNON HOWE & CO LLC (686,635 shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.